4.2485
price down icon0.39%   -0.0165
after-market After Hours: 4.25 0.0015 +0.04%
loading
Collplant Biotechnologies Ltd stock is traded at $4.2485, with a volume of 21,051. It is down -0.39% in the last 24 hours and up +6.95% over the past month. CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$4.265
Open:
$3.55
24h Volume:
21,051
Relative Volume:
1.83
Market Cap:
$45.82M
Revenue:
$10.96M
Net Income/Loss:
$-7.02M
P/E Ratio:
-6.7437
EPS:
-0.63
Net Cash Flow:
$-3.72M
1W Performance:
+0.44%
1M Performance:
+6.95%
6M Performance:
-26.26%
1Y Performance:
-24.81%
1-Day Range:
Value
$3.51
$4.25
1-Week Range:
Value
$3.31
$4.33
52-Week Range:
Value
$3.31
$6.99

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name
Name
Collplant Biotechnologies Ltd
Name
Phone
-
Name
Address
-
Name
Employee
73
Name
Twitter
@CollplantBio
Name
Next Earnings Date
2024-12-27
Name
Latest SEC Filings
Name
CLGN's Discussions on Twitter

Compare CLGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CLGN
Collplant Biotechnologies Ltd
4.2485 45.82M 10.96M -7.02M -3.72M -0.63
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
464.56 119.70B 10.63B -479.80M -1.35B 13.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
754.87 82.75B 13.85B 4.65B 3.32B 35.06
Biotechnology icon
ARGX
Argen X Se Adr
614.59 36.73B 1.86B -40.29M -1.28B -4.16
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.74 32.53B 2.09B -332.26M 16.06M -4.14
Biotechnology icon
BNTX
Biontech Se Adr
120.72 28.50B 3.30B -501.07M 1.03B 11.54

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-17-23 Initiated Alliance Global Partners Buy

Collplant Biotechnologies Ltd Stock (CLGN) Latest News

pulisher
Nov 27, 2024

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire

Nov 27, 2024
pulisher
Nov 26, 2024

What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings - GuruFocus.com

Nov 26, 2024
pulisher
Nov 23, 2024

Collplant stock hits 52-week low at $3.56 amid market challenges - Investing.com Canada

Nov 23, 2024
pulisher
Nov 22, 2024

Collplant stock hits 52-week low at $3.56 amid market challenges By Investing.com - Investing.com South Africa

Nov 22, 2024
pulisher
Nov 20, 2024

CollPlant Biotechnologies (CLGN) Set to Announce Earnings on Wednesday - Defense World

Nov 20, 2024
pulisher
Nov 12, 2024

CollPlant (CLGN) to Report Q3 2024 Earnings on Nov 27: Conference Call Details | CLGN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION – Company AnnouncementFT.com - Financial Times

Nov 12, 2024
pulisher
Nov 09, 2024

Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Invest In Growth - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Collplant stock hits 52-week low at $3.61 amid market challenges - Investing.com Australia

Nov 09, 2024
pulisher
Nov 08, 2024

500: Something went wrong - Investing.com India

Nov 08, 2024
pulisher
Nov 01, 2024

Collplant stock hits 52-week low at $3.75 amid market challenges - Investing.com Australia

Nov 01, 2024
pulisher
Oct 25, 2024

EF Hutton Initiates Coverage of CollPlant Biotechnologies (CLGN) with Buy Recommendation - MSN

Oct 25, 2024
pulisher
Oct 23, 2024

Collplant stock hits 52-week low at $4.05 amid market challenges - Investing.com India

Oct 23, 2024
pulisher
Oct 21, 2024

Collplant stock hits 52-week low at $4.05 amid market challenges By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 01, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Update - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 5.3% in September - MarketBeat

Oct 01, 2024
pulisher
Sep 27, 2024

Benjamin F. Edwards & Company Inc. Sells 10,690 Shares of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World

Sep 27, 2024
pulisher
Sep 25, 2024

CollPlant Shareholders Approve Key Proposals - TipRanks

Sep 25, 2024
pulisher
Sep 16, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short Interest - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

3D Bioprinting Market valued at USD 1.41 billion in 2024 | ExactitudeConsultancy - GlobeNewswire

Sep 16, 2024
pulisher
Sep 02, 2024

CollPlant (CLGN), Stratasys Initiate Study for Breast Implants - MSN

Sep 02, 2024
pulisher
Aug 29, 2024

CollPlant and Stratasys Launch Pre-clinical Trial for Regenerative 3D-Printed Breast Implants - 3DPrint.com

Aug 29, 2024
pulisher
Aug 27, 2024

The Stratasys’ Origin® printer to be tested for CollPlant’s 3D-printed breast implants - 3d adept media

Aug 27, 2024
pulisher
Aug 26, 2024

HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN) - MarketBeat

Aug 26, 2024
pulisher
Aug 26, 2024

Head-To-Head Analysis: Envoy Medical (NASDAQ:COCH) and CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Aug 26, 2024
pulisher
Aug 26, 2024

HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.’s Q3 2024 Earnings (NASDAQ:CLGN) - Defense World

Aug 26, 2024
pulisher
Aug 23, 2024

FY2027 EPS Estimates for CollPlant Biotechnologies Ltd. Reduced by HC Wainwright (NASDAQ:CLGN) - MarketBeat

Aug 23, 2024
pulisher
Aug 23, 2024

HC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World

Aug 23, 2024
pulisher
Aug 22, 2024

Global Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18% - GlobeNewswire Inc.

Aug 22, 2024
pulisher
Aug 22, 2024

CollPlant Schedules Shareholder Meeting - Investing.com India

Aug 22, 2024
pulisher
Aug 21, 2024

CollPlant Schedules Shareholder Meeting By Investing.com - Investing.com Australia

Aug 21, 2024
pulisher
Aug 21, 2024

Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies - Benzinga

Aug 21, 2024
pulisher
Aug 21, 2024

CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at HC Wainwright - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 21, 2024
pulisher
Aug 21, 2024

Earnings call: CollPlant Biotechnologies reports Q2 2024 financials By Investing.com - Investing.com Australia

Aug 21, 2024
pulisher
Aug 21, 2024

CollPlant Biotechnologies Ltd (CLGN) Q2 2024 Earnings Call Trans - GuruFocus.com

Aug 21, 2024
pulisher
Aug 20, 2024

Q2 2024 Collplant Biotechnologies Ltd Earnings Call Transcript - GuruFocus.com

Aug 20, 2024
pulisher
Aug 20, 2024

CollPlant Announces Upcoming Shareholder Meeting - TipRanks

Aug 20, 2024
pulisher
Aug 20, 2024

Collplant stock hits 52-week low at $4.1 amid market challenges - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Even after rising 10% this past week, CollPlant Biotechnologies (NASDAQ:CLGN) shareholders are still down 71% over the past three years - Yahoo Finance

Aug 20, 2024
pulisher
Aug 20, 2024

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Nasdaq

Aug 20, 2024
pulisher
Aug 20, 2024

We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow - Simply Wall St

Aug 20, 2024
pulisher
Aug 19, 2024

CollPlant and Stratasys launch pre-clinical study for 3D implants - Investing.com India

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Earnings per Share (Dil - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Cash Flow for Lease Fin - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant Biotechnologies (FRA:CPT) Market Cap : €48.54 Mil (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant and Stratasys announce pre-clinical study for regenerative breast implants - Med-Tech Innovation

Aug 19, 2024
pulisher
Aug 19, 2024

Stratasys and CollPlant commence pre-clinical study for 3D printed regenerative breast implants - TCT Magazine

Aug 19, 2024
pulisher
Aug 19, 2024

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants - Lelezard

Aug 19, 2024

Collplant Biotechnologies Ltd Stock (CLGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):